When I am bullish on a company I augment my long holdings with an equal number of calls. I thought about doubling down when it hit 18.5 a few days ago, but only added 10%., A bit cautious after the november and december action.
When you read the transcripts it has the flavor of a man who has been building a deal for a while and it is about to go through. My seat-of-the-pants target is 27 by year's end.
Are you familiar with Zoginex? Alkermes does some work with them. Big insider purchases there last month after a flawed FDA advisory panel rejection of zohydro.